Pleuropulmonary Blastoma - Classification, Diagnosis, and Treatment

What Is Pleuropulmonary Blastoma?

Pleuropulmonary blastomas are uncommon malignant mesenchymal tumors that often cause non-specific symptoms. Although radiologic characteristics may raise clinical suspicion for this illness, a pleuropulmonary blastoma is diagnosed only based on microscopic findings.

Childhood lung tumors are uncommon malignant tumors that account for 0.5 % to 1 % of all initial malignant lung tumors.

What Is the Classification of Pleuropulmonary Blastoma?

These tumors have three forms:

1. Pulmonary blastoma.

2. Fetal adenocarcinoma.

3. Pleuropulmonary blastoma (PPB).

What Is Fetal Adenocarcinoma?

An epithelial malignant and immature component distinguishes fetal adenocarcinoma. Pleuropulmonary blastoma is characterized by malignant adolescent mesenchymal growth. Biphasic members define blastoma as a mesenchymal and an epithelial malignant and ignorant part that resembles a 10 to 16-week gestational lung. Fetal adenocarcinoma was classified as cancer by the World Health Organization in 2015.

What Is Pleuropulmonary Blastoma?

Belonging to the adenocarcinoma group, pulmonary blastoma belongs to the sarcomatoid carcinoma group, and pleuropulmonary blastoma belongs to the mesenchymal tumors group. Pleuropulmonary blastomas are uncommon tumors that cause non-specific symptoms despite the relevance of radiologic characteristics in suspecting the diagnosis.

What Is the Epidemiology of Pleuropulmonary Blastoma?

Pleuropulmonary blastomas are typically diagnosed before the age of four. They are classified as follows:

Type I: Pleuropulmonary tumors are pure cystic tumors in children under two, with a median age of ten months.

Type II: Pleuropulmonary tumors are cystic and solid tumors that develop at a median age of 35 months.

Type III: Pleuropulmonary tumors are solid tumors arising at a median age of 41 month

What Is the Etiology of Pleuropulmonary Blastoma?

In 40 % of the instances, genetic forms have been detected. The condition is the pleuropulmonary blastoma family tumor and dysplasia syndrome. Patients develop neoplastic and dysplastic illnesses throughout their first five to six years, with rare adolescent instances. Some families lacking DICER 1 staining in epithelial cells have inherited DICER 1 loss-of-function mutations. However, the majority of mutation carriers are unaffected. Genetic variants should be investigated when dealing with individuals with different symptoms besides respiratory problems, such as irregular menstrual cycles or other symptoms connected to sex hormone production.

What Is the Pathophysiology of Pleuropulmonary Blastoma?

Polysomy of chromosome eight is a consistent hallmark of pleuropulmonary blastoma. The expansion of mesenchymal elements mainly causes clonal proliferation, whereas epithelial components are typically non-neoplastic. Pleuropulmonary blastoma can come from the mediastinum, diaphragm, and pleura, as well as the lung. This has raised the prospect of pleuropulmonary blastoma arising from the splanchnopleuric mesoderm. The brain, liver, bone, lymph nodes, kidney, pancreas, and adrenal glands are common metastatic locations.

What Are the Histological Features of Pleuropulmonary Blastoma?

The gross findings differ depending on the kind of pleuropulmonary blastoma:

Type I: Thin-walled structures characterize pleuropulmonary cancers.

Type II: Solid and cystic lesions coexist in pleuropulmonary tumors.

Type III: Pleuropulmonary tumors manifest as a mass with a variegated cut surface that may be hemorrhagic or necrotic.

What Are the Signs and Symptoms of Pleuropulmonary Blastoma?

Signs and symptoms change depending on the subtype:

• Type I tumors cause respiratory discomfort from air-filled cysts squeezing on airways, with or without pneumothorax.

• Dyspnea and chest discomforts are symptoms of type II and III tumors.

• These children may exhibit pneumonia or other nonspecific symptoms such as cough, fever, trouble breathing, weariness, lack of energy, and decreased appetite.

• It is also found that asymptomatic lesions are detected by a chest wall deformity or a stress pneumothorax.

How is Pleuropulmonary Blastoma Diagnosed?

• Pleuropulmonary blastomas typically affect both the lung and the pleura.

• The computed tomography (CT) scan results indicate either a mass or a consolidation.

• Multiloculated cystic or solid alterations are also possible.

• Fifty to sixty percent of type I lesions are confined to the lungs.

• Type II and III lesions are more likely to spread outside the lung.

• In around 25 % of individuals, pleuropulmonary blastomas appear to have a constitutional and heritable propensity to other dysplastic or neoplastic illnesses.

• Thyroid neoplasia, medulloblastoma, malignant germ cell tumor, and other diseases.

• As a result, all individuals with pleuropulmonary blastomas and their relatives should be closely examined.

What Is the Treatment of Pleuropulmonary Blastoma?

• Patients with type I tumors are treated with surgical resection to identify and treat cancer.

• Although adjuvant chemotherapy is also suggested.

• Radiation therapy is not employed in the treatment of type I pleuropulmonary blastoma.

• If a child's type I pleuropulmonary blastoma recurs as type II or type III pleuropulmonary blastoma, the treatment options for types II and III illnesses are applied.

• Both type II and type III pleuropulmonary blastoma are aggressive cancers. Therefore, surgical excision of type II and III lesions is suggested, followed by chemotherapy or radiation treatment.

• The use of intracavitary chemotherapy also shows favorable results.

• There is an advantage to Doxorubicin-based regimens, and recurrence is frequently local.

• Individualized radiation treatment can be employed in pleuropulmonary blastoma patients.

• In general, radiation can be considered if a small portion of the tumor cannot be removed surgically and is resistant to chemotherapy.

• Pleuropulmonary blastomas can spread broadly.

• Surgery is frequently recommended, followed by radiation therapy when pleuropulmonary blastoma progresses to the brain.

• High-dose consolidation treatment with autologous stem cell rescue for frequent malignancies can also be done.

What Is the Differential Diagnosis of Pleuropulmonary Blastoma?

The differential diagnosis of pleuropulmonary blastoma is:

• Cystic mesenchymal hamartoma.

• Rhabdomyosarcoma of the lungs.

• Hamartoma mesenchymal cystic.

• Pulmonary blastoma in children.

• Neuroblastoma.

• Lung cystic rhabdomyosarcoma.

What Is the Prognosis of Pleuropulmonary Blastoma?

People with type I tumors have an 80 % to 90 % chance of surviving five years disease-free. People with type II and III tumors have a five-year disease-free survival rate of less than 50 %.

Conclusion:

Pleuropulmonary blastomas are uncommon in youngsters. They appear in various ways and are best handled by an interprofessional team, including oncology nurses. Surgery is the preferred treatment. Any criteria deal with each situation based on personal experience and available resources. Surgical excision of type II and III lesions is suggested, followed by chemotherapy and radiation treatment. The use of intracavitary chemotherapy has been documented in the literature. There is an advantage to Doxorubicin-based regimens. Recurrence is frequently local. Pleuropulmonary blastomas can spread broadly. High-dose consolidation treatment with autologous stem cell rescue for frequent malignancies can also be done.